Vitamin D Analog in Vitamin D 24-hydroxylase Deficiency
Recruiting
N/A
Interventional Study
Idiopathic Infantile Hypercalcemia - Severe Form
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 30 (estimated)
- Sponsor
- University Hospital, Caen · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Preclinical evaluation of a vitamin D analog for the treatment of vitamin D 24-hydroxylase using fibroblast from patients with CYP24A1 mutation.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* biallelic mutation in CYP24A1
* consent
Exclusion Criteria:
* none
Contacts
No contact information available.